The article presents a study related to a drug which promotes the death of cancer cells and prevents death of cells in post-ischemic neurons. It is mentioned that cancer chemotherapeutic agent ABT-737 can also can also prevent neuronal death after brain ischemiareperfusion. The study is based on the concern of why the anti-apoptotic effects of ABT-737 trump the expected pro-apoptotic effects in post-ischemic neurons, but not in cancer cells.